报价延迟最少15分钟:2026/03/02 22:36 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
30 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.38/-4.51
|
|
企业价值
2.00B
|
| 资产负债 |
|
每股账面净值
9.00
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
7.02M
|
|
每股收益
0.07
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care. |
